share_log

Natural Shrimp Announces Filing of Application to List on Cboe US

Natural Shrimp Announces Filing of Application to List on Cboe US

天然蝦宣佈申請在美國芝加哥期權交易所上市
PR Newswire ·  04/17 20:30

Company also Extending Engagement with Investment Banking Partner to Underwrite Capital Raise

公司還擴大了與投資銀行合作伙伴的合作範圍以承保融資

DALLAS, April 17, 2024 /PRNewswire/ -- Natural Shrimp Incorporated (OTCQB: SHMP), a Biotechnology Aquaculture Company (the "Company") that has developed and patented the first seafood-focused commercially operational RAS (Recirculating Aquaculture System), is pleased to announce that the Company has filed an initial application to list its securities on the Chicago Board of Options Exchange (Cboe US) BZX exchange (the "Exchange"). In addition, the Company has extended its engagement with its investment banking partner to underwrite a capital raise concurrent with the Cboe US listing.

達拉斯,2024年4月17日 /PRNewswire/ — 生物技術水產養殖公司(以下簡稱 “公司”)Natural Shrimp Incorporated(OTCQB:SHMP)很高興地宣佈,該公司已首次申請在芝加哥期權交易所(Cboe US)BZX交易所(“交易所”)上市,該公司已首次申請將其證券在芝加哥期權交易所(Cboe US)BZX交易所(“交易所”)上市。)。此外,該公司還擴大了與投資銀行合作伙伴的合作範圍,以承保與芝加哥期權交易所美國上市同時進行的融資。

The Company has also begun the restructuring process of its existing debt and mezzanine securities in order to meet Cboe US' shareholders' equity requirements and has identified a lead investor of up to $1.5M of an anticipated capital raise of between $5M-$10M.

該公司還開始了現有債務和夾層證券的重組進程,以滿足芝加哥期權交易所美國股東權益要求,並已確定了預期籌資500萬至1,000萬美元中的高達150萬美元的主要投資者。

Historically, for micro- and small-cap companies in particular, there were only two options when choosing a senior exchange on which to execute their initial public offering, uplisting or cross-listing transaction: the Nasdaq Capital Market (Nasdaq) or the NYSE American (NYSE). As recently as mid-2023, a third option emerged when Cboe Global Markets made it possible for companies to list on its U.S. market. This has now made it possible for micro- and small-cap companies to choose an alternative for their stakeholders' benefit.

從歷史上看,特別是對於微型和小型股公司而言,在選擇高級交易所進行首次公開募股、上市或交叉上市交易時,只有兩種選擇:納斯達克資本市場(納斯達克)或紐約證券交易所美國證券交易所(NYSE)。就在2023年年中,當芝加哥期權交易所環球市場使公司有可能在美國市場上市時,出現了第三種選擇。現在,這使微型和小型股公司有可能爲利益相關者的利益選擇替代方案。

While Cboe US as a senior exchange is new for issuers, Cboe is not new to the exchange arena, having just celebrated its 50th anniversary in 2023 as a world leader in options trading, including having run stock exchanges in several countries over the last decade, including the U.S. where it has become home to over 650 ETFs. Now, Cboe US is channeling that expertise toward building out this third senior exchange for public companies. NaturalShrimp is excited to be a benefactor of that for its stakeholders.

儘管Cboe US作爲高級交易所對發行人來說是新事物,但Cboe對交易所領域並不陌生,因爲Cboe剛剛慶祝了其50強第四 2023年是期權交易領域的全球領導者,週年紀念日,包括在過去十年中在多個國家經營證券交易所,其中包括美國,它已成爲650多隻ETF的發源地。現在,Cboe US正在利用這些專業知識來建設第三家上市公司高級交易所。NaturalShrimp很高興能成爲其利益相關者的捐贈者。

Gerald Easterling, CEO of Natural Shrimp stated "After several weeks of meetings and due diligence, Natural Shrimp is pleased to announce this next step in our evolution. This listing will expose the company to many more institutional investors in the U.S., Europe, and Asia. We believe that we have completed all the requirements and documentation to quickly move to this exchange. Also, we are expecting to extend our investment banking relationship as part of this process."

天然蝦業首席執行官傑拉爾德·伊斯特林表示:“經過數週的會議和盡職調查,天然蝦很高興地宣佈我們的下一步發展。此次上市將使該公司接觸到美國、歐洲和亞洲的更多機構投資者。我們認爲,我們已經完成了所有要求和文件,可以迅速轉向此交易所。此外,作爲這一過程的一部分,我們預計將擴大我們的投資銀行關係。”

William Delgado, CFO of Natural added "We have been working on the uplist process for the better part of two years. The predominant small cap uplist exchange has seen a significant reduction in both the number of uplists and IPOs. We have been in discussions with the Cboe US for the past several weeks and truly believe that their new platform is going to change the micro and small cap marketplace and be of significant benefit to NaturalShrimp and provide liquidity to our shareholders."

Natural首席財務官威廉·德爾加多補充說:“在兩年的大部分時間裏,我們一直在研究上市流程。占主導地位的小盤股上市交易所的上市數量和首次公開募股數量均大幅減少。在過去的幾周裏,我們一直在與美國芝加哥期權交易所進行討論,並堅信他們的新平台將改變微型和小盤股市場,爲NaturalShrimp帶來重大利益,併爲我們的股東提供流動性。”

The Company expects to announce new market opportunities, completion and capitalization of its existing facilities, and new domestic and international expansion opportunities in the coming weeks.

該公司預計將在未來幾周內宣佈新的市場機會、現有設施的竣工和資本化以及新的國內和國際擴張機會。

About Natural Shrimp

關於天然蝦

Natural Shrimp, Incorporated is a publicly traded aquaculture Company, headquartered in Dallas, with production facilities located near San Antonio, Texas, and Webster City, Iowa. The Company has developed the first commercially viable system for growing shrimp in enclosed salt-water systems using patented technology to produce fresh, naturally grown shrimp, without the use of antibiotics or toxic chemicals. Natural Shrimp systems can be located anywhere in the world to produce gourmet-grade Pacific white shrimp. For more information visit .

Natural Shrimp, Incorporated是一家上市的水產養殖公司,總部位於達拉斯,其生產設施位於德克薩斯州的聖安東尼奧和愛荷華州的韋伯斯特城附近。該公司開發了第一個商業上可行的系統,用於在封閉的鹽水系統中種植蝦,使用專利技術生產新鮮的天然生長蝦,不使用抗生素或有毒化學物質。天然對蝦系統可以位於世界任何地方,生產美食級太平洋白蝦。欲了解更多信息,請訪問。

Forward-Looking Statements

前瞻性陳述

This press release contains a number of forward-looking statements that reflect management's current views with respect to future events and financial performance. Forward-looking statements are projections in respect of future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology such as "may," "should," "expects," "plans," "anticipates," "believes," "estimates," "predicts," "potential" or "continue" or the negative of these terms or other comparable terminology. These statements include statements regarding the intent, belief or current expectations of us and members of our management team, as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risk and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties and other factors, including the risks set forth in the section entitled "Risk Factors" in the Company's Annual Report on Form 10-K for the fiscal year ended March 31, 2022, any of which may cause our company's or our industry's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied in our forward-looking statements.

本新聞稿包含許多前瞻性陳述,反映了管理層當前對未來事件和財務業績的看法。前瞻性陳述是對未來事件或我們未來財務業績的預測。在某些情況下,您可以通過諸如 “可能”、“應該”、“期望”、“計劃”、“預期”、“相信”、“估計”、“預測”、“潛在” 或 “繼續” 等術語來識別前瞻性陳述,或者這些術語或其他類似術語的否定詞。這些陳述包括有關我們和管理團隊成員的意圖、信念或當前期望的陳述,以及此類陳述所依據的假設。提醒潛在投資者,任何此類前瞻性陳述都不能保證未來的表現,並涉及風險和不確定性,實際業績可能與此類前瞻性陳述所設想的結果存在重大差異。這些陳述僅是預測,涉及已知和未知的風險、不確定性和其他因素,包括公司截至2022年3月31日財年的10-K表年度報告中標題爲 “風險因素” 的部分中列出的風險,其中任何風險都可能導致我們公司或行業的實際業績、活動水平、業績或成就與我們的前瞻中表達或暗示的任何未來業績、活動水平、業績或成就存在重大差異聲明。

SOURCE NaturalShrimp Inc

來源 NaturalShrimp Inc

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論